Historically, AXIN1 and CTNNB1 mutations in HCC were considered functionally equivalent, as cell lines harboring mutations in either gene displayed increased complex formation between β-catenin and TCF/LEF, indicative of Wnt pathway activation.8 Here, AXIN1 is linked to hepatocellular carcinoma.